Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 14 de may. de 2024 · En base a la documentación consultada, la técnica de rescate celular (“salva células” o “cell salvage”) intraoperatorio parece ser segura en pacientes con cáncer que se someten a cirugía oncológica. Su uso no parece asociarse a una menor supervivencia o a un aumento de la recurrencia del cáncer, aunque la evidencia ...

  2. 13 de may. de 2024 · Season 4: Loot Reborn takes on a new theme, overhauling many core game systems to refresh how items are earned, how they function, and how they improve as you level through World Tiers during the season. Loot Reborn brings global changes to itemization as well as tempering and masterworking. These changes are also paired with changes to affixes ...

  3. 12 de may. de 2024 · Aspects are no longer stored in the inventory, clogging everything up! When you salvage a legendary item, its Aspect will go directly to the Codex. If it’s a new Aspect for you, it will start at rank 1, and each subsequent copy you salvage will increase the rank, until the maximum of 16.

  4. 30 de abr. de 2024 · In addition, the authors note that autologous blood donor donation as well as autologous blood salvage with cell-saver is generally not cost efficient. Blood transfusions appear to be overused. The first of the articles in the series by Goodnough and colleagues focuses on this issue and is summarized in "Study Highlights."

  5. More plasma in less time. Haemonetics launches the PCS® plasma collection system, significantly cutting the time needed to collect plasma and increasing donor safety. High-speed technology. Cell Saver® 4, the first automated high-speed blood salvage technology, is launched. A private company.

  6. 4 de may. de 2024 · Primary outcomes included intraoperative blood product transfusion volumes for pRBC, FFP, cryoprecipitate, autologous blood salvage, and platelets. Secondary outcomes included CPB time, ICU length of stay, and post-bypass VIS.

  7. 20 de may. de 2024 · PDF. Tools. Share. Abstract. Background. Patients with relapsed primary mediastinal nonseminomatous germ cell tumor have low cure rates with salvage chemotherapy or surgery. The authors report survival outcomes of patients who received high-dose chemotherapy (HDCT) and peripheral blood stem cell transplantation (PBSCT) at Indiana University.